Feed TRLV
TR

Trulieve Cannabis Corp. TRLV · NYSE

$10.28 +2.70% (+$0.27)

Summary

46 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $325.4M against $260.6M.
  • Out of every 100 USD of revenue, 16 USD is left as free cash.

What to watch

  • The company made a loss over the last 12 months.
  • The price moves much more than the market (beta 1.81).

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

There is not enough revenue history yet to say how fast it grows.

Growth in detail

Does it make money?

Reasonably

Over the last 12 months it made a loss of $473.4M.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.4 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $15 is 46% above today's price. 100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.